Apotex Research Private Limited, a active private limited company, was established on 16 June 2003 in Jigani Hobli, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U73100KA2003PTC032103. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹460.00 Cr and a paid-up capital of ₹291.86 Cr.
It upholds a compliant status. Employing 1,236 professional, Its leadership includes Brian George Mcclelland (Director), Rajesh Salwan (Additional Director), Goutam Vilas Pujari (Director). Past directors included Brian George Mcclelland, Robert Craig Baxter, Jeremy Bharat Desai. It holds ₹483.80 Cr open charges and no settled loans. Its latest AGM occurred on 24 September 2024, with the balance sheet filed on 31 March 2024. It is based at Site No.1,Bommasandra Industrial Area, 1V Th Phase, Jigani Link Road,, Jigani Hobli, Karnataka, 562158.
U73100KA2003PTC032103
032103
16 June 2003
₹460.00 Cr
₹291.86 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Apotex Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Brian George Mcclelland | Director | 15 Sep 2023 | Current |
| Rajesh Salwan | Additional Director | 18 Mar 2025 | Current |
| Goutam Vilas Pujari | Director | 01 Dec 2018 | Current |
| Uta Kellermann Renton | Additional Director | 18 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 Sep 2023 | Past |
| Pramod Abcsdd | Director | 16 Jan 2015 | Past |
| Pramod Abcsdd | Director | 08 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Additional Director | 23 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apotex Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.82% increase. The company also saw a substantial improvement in profitability, with a 109.79% increase in profit. The company's net worth dipped by a decrease of 0.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Apotex Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,838,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2023 | Others | ₹30.00 Cr | Open |
| 09 Jun 2017 | Others | ₹5.00 Cr | Open |
| 24 Mar 2016 | The Hongkong And Shanghai Banking Corporation Limited | ₹8.00 M | Open |
| 17 Oct 2012 | The Hongkong And Shanghai Banking Corporation Limited | ₹198.00 Cr | Open |
| 31 Mar 2006 | Apotex Pharmaceutical Holdings Inc | ₹250.00 Cr | Open |
Explore comprehensive loan charge details -
Apotex Research has a workforce of 1236 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Apotex Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apotex Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Shama Shridhar Doddawad was appointed as a Cfo was appointed as a Cfo on 18 Apr 2025 & has been associated with this company since 7 months 11 days . was completed.
The activity Rajesh Salwan was appointed as a Additional Director was appointed as a Additional Director on 18 Mar 2025 & has been associated with this company since 8 months 11 days . was completed.
Progress on Uta Kellermann Renton was appointed as a Additional Director was appointed as a Additional Director on 18 Mar 2025 & has been associated with this company since 8 months 11 days . was documented.
Apotex Research Private Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Apotex Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
A charge with Others amounted to Rs. 30.00 Cr with Charge ID 100801520 was registered on 30 Sep 2023. was recorded as a recent event.
The CIN of Apotex Research Private Limited is U73100KA2003PTC032103.
Apotex Research Private Limited is headquartered at Site No.1,Bommasandra Industrial Area, 1V Th Phase, Jigani Link Road,, Jigani Hobli, Karnataka, 562158.
Apotex Research Private Limited was incorporated on 16 June 2003.
The current directors of Apotex Research Private Limited are
The primary industry of Apotex Research Private Limited is Manufacturing.
Apotex Research Private Limited is unlisted.
The authorized capital of Apotex Research Private Limited is ₹460.00 Cr, and the paid-up capital is ₹291.86 Cr.
The compliance status of Apotex Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX